Project description
Collaboration for nanoparticles in cancer therapy
Nanotechnology, the study of extremely small particles, has immense application potential in medical research. Iron-oxide nanoparticles will have an important role in cancer therapy, diagnosis and surgery in the near future. The MaNaCa project will create a base for research and for scientific and technological efficiency. The Institute of the National Academy of Sciences (IPR-NAS) in Armenia will network with Greece’s Aristotle University in Thessaloniki, and the German University of Duisburg-Essen. Together, they will be supported by the consultancy company Intelligentsia Consultants Sarl on the subject of magnetic nanohybrids used in cancer therapy for three years.
Fields of science
Programme(s)
- H2020-EU.4.b. - Twinning of research institutions Main Programme
Topic(s)
Funding Scheme
CSA - Coordination and support action
Coordinator
0203 Ashtarak
Armenia
See on map
Participants (3)
546 36 Thessaloniki
See on map
45141 Essen
See on map
8086 Bertrange
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.